Penumbra (PEN) Share-based Compensation (2014 - 2026)

Penumbra's (PEN) quarterly Share-based Compensation came in at $14.6 million in Q1 2026, up 1647.61% year-on-year from $838000.0 in Q1 2025, and up 135.37% on a QoQ basis from -$41.4 million in Q4 2025.

Penumbra (PEN) Share-based Compensation (2014 - 2026) Analysis & Trends

Penumbra (PEN) has 13 years of Share-based Compensation data on file, last reported at $14.6 million in Q1 2026.

  • On a quarterly basis, Share-based Compensation rose 1647.61% year-over-year to $14.6 million in Q1 2026; TTM through Mar 2026 was $16.4 million, a 482.99% increase from a year earlier, with the FY2025 full-year figure at $2.5 million, up 6.62% from the prior year.
  • Share-based Compensation for Q1 2026 stood at $14.6 million, up from -$41.4 million in the prior quarter.
  • Over the last five years, Share-based Compensation for PEN reached as high as $49.4 million in Q4 2023 and fell as low as -$43.5 million in Q4 2022.
  • Historically, Share-based Compensation has averaged $4.6 million across 5 years, with a median of $838000.0 in 2025.
  • On a YoY basis, Share-based Compensation climbed as much as 559416.67% in 2024 and fell as far as 164.17% in 2024.
  • Year by year, Share-based Compensation stood at -$43.5 million in 2022, then soared by 213.61% to $49.4 million in 2023, then slumped by 164.17% to -$31.7 million in 2024, then tumbled by 30.69% to -$41.4 million in 2025, then jumped by 135.37% to $14.6 million in 2026.
  • Per Business Quant data, the three most recent Share-based Compensation figures were $14.6 million in Q1 2026, -$41.4 million in Q4 2025, and $41.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Abbott Laboratories 182.44 Bn 175.14 Bn 6.27 Bn 317.00 Mn
2 Stryker 128.91 Bn 126.03 Bn 3.81 Bn 139.00 Mn
3 Medtronic 108.67 Bn 99.45 Bn 6.41 Bn 95.00 Mn
4 Boston Scientific 68.45 Bn 67.00 Bn 3.61 Bn 83.00 Mn
5 Edwards Lifesciences 47.59 Bn 43.92 Bn 1.29 Bn 45.40 Mn
6 Dexcom 28.59 Bn 27.48 Bn 750.30 Mn 35.80 Mn
7 GE HealthCare Technologies 28.53 Bn 26.24 Bn 1.98 Bn 35.00 Mn
8 Smith & Nephew 26.95 Bn 26.37 Bn - -
9 Koninklijke Philips 25.42 Bn 22.30 Bn 2.07 Bn 35.12 Mn
10 Penumbra 12.56 Bn 11.95 Bn 253.41 Mn 14.65 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 14.65 Mn
Mar 31, 2026 14.65 Mn
Dec 31, 2025 -41.41 Mn
Dec 31, 2025 -41.41 Mn
Sep 30, 2025 41.14 Mn
Sep 30, 2025 41.14 Mn
Jun 30, 2025 1.98 Mn
Jun 30, 2025 1.98 Mn
Mar 31, 2025 838,000.00
Mar 31, 2025 838,000.00
Dec 31, 2024 -31.68 Mn
Dec 31, 2024 -31.68 Mn
Sep 30, 2024 33.56 Mn
Sep 30, 2024 33.56 Mn
Jun 30, 2024 89,000.00
Jun 30, 2024 89,000.00
Mar 31, 2024 421,000.00
Mar 31, 2024 421,000.00
Dec 31, 2023 49.37 Mn
Dec 31, 2023 49.37 Mn